Literature DB >> 8697187

Effects of the corticotropin-releasing factor (CRF) on rectal afferent nerves in humans.

T Lembo1, V Plourde, Z Shui, S Fullerton, H Mertz, Y Tache, B Sytnik, J Munakata, E Mayer.   

Abstract

Corticotropin-releasing factor (CRF) released in the gastrointestinal mucosa from immune cells or enterochromaffin cells may play a role in the modulation of rectal afferent function. In the current study we evaluated the effects of peripherally administered CRF on afferent mechanisms in the human rectum. We used rectal balloon distention in seven healthy volunteers to evaluate the effect of CRF (1 microgram/kg) on visceral afferents originating in the rectum which are involved in the following functions: thresholds and intensity of conscious perception, receptive relaxation, reflex inhibition of internal anal sphincter and a viscerosomatic reflex. Rectal mechanoreceptors were stimulated either by distending the rectum using a volume ramp (40 and 400 mL/min), or by intermittent phasic distention. CRF decreased the thresholds and increased the intensity for the sensation of discomfort in response to both ramp and phasic distention. During slow ramp distention, CRF also lowered the stool threshold. CRF increased rectal compliance during slow ramp distention without affecting the rate of receptive relaxation or the inflection point of the compliance curve. CRF had no effect on viscerosomatic referral patterns, or on the rectoanal inhibitory reflex. These findings are consistent with a dual effect of CRF on afferent pathways mediating perception of aversive rectal sensations, and on rectal smooth muscle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8697187     DOI: 10.1111/j.1365-2982.1996.tb00237.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  32 in total

1.  Role of corticotropin-releasing factor in stress-related visceral hyperalgesia.

Authors:  Hiroshi Kaneko
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

2.  Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain.

Authors:  Catherine S Hubbard; Jennifer S Labus; Joshua Bueller; Jean Stains; Brandall Suyenobu; George E Dukes; Dennis L Kelleher; Kirsten Tillisch; Bruce D Naliboff; Emeran A Mayer
Journal:  J Neurosci       Date:  2011-08-31       Impact factor: 6.167

3.  Sensational developments in the irritable bowel.

Authors:  B Naliboff; E A Mayer
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

Review 4.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

5.  Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress.

Authors:  I Posserud; P Agerforz; R Ekman; E S Björnsson; H Abrahamsson; M Simrén
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 6.  CRF1 receptor signaling pathways are involved in stress-related alterations of colonic function and viscerosensitivity: implications for irritable bowel syndrome.

Authors:  Y Taché; V Martinez; L Wang; M Million
Journal:  Br J Pharmacol       Date:  2004-04       Impact factor: 8.739

7.  Therapeutic advances in functional gastrointestinal disease: irritable bowel syndrome.

Authors:  Alexandru Gaman; Maria Cristina Bucur; Braden Kuo
Journal:  Therap Adv Gastroenterol       Date:  2009-05-01       Impact factor: 4.409

8.  Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin.

Authors:  P-Q Yuan; S V Wu; L Wang; Y Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

9.  Effect of a corticotropin releasing hormone receptor antagonist on colonic sensory and motor function in patients with irritable bowel syndrome.

Authors:  Y Sagami; Y Shimada; J Tayama; T Nomura; M Satake; Y Endo; T Shoji; K Karahashi; M Hongo; S Fukudo
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

10.  Corticotropin releasing factor receptor antagonists: potential future therapy in gastroenterology?

Authors:  Y Taché
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.